Previous Article | Next Article 
Journal of Virology, November 1998, p. 8813-8819, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Vaccinia Virus Protein Synthesis Has a Low
Requirement for the Intact Translation Initiation Factor eIF4F, the
Cap-Binding Complex, within Infected Cells
Jacqueline
Mulder,
Morwenna
E. M.
Robertson,
Rachael A.
Seamons, and
Graham J.
Belsham*
BBSRC Institute for Animal Health, Pirbright,
Woking, Surrey GU24 ONF, United Kingdom
Received 5 May 1998/Accepted 24 July 1998
 |
ABSTRACT |
The role of the cap-binding complex, eIF4F, in the translation of
vaccinia virus mRNAs has been analyzed within infected cells. Plasmid
DNAs, which express dicistronic mRNAs containing a picornavirus internal ribosome entry site, produced within vaccinia virus-infected cells both
-glucuronidase and a cell surface-targeted single-chain antibody (sFv). Cells expressing sFv were selected from nonexpressing cells, enabling analysis of protein synthesis specifically within the
transfected cells. Coexpression of poliovirus 2A or foot-and-mouth disease virus Lb proteases, which cleaved translation initiation factor
eIF4G, greatly inhibited cap-dependent protein (
-glucuronidase) synthesis. Under these conditions, internal ribosome entry
site-directed expression of sFv continued and cell selection was
maintained. Furthermore, vaccinia virus protein synthesis persisted in
the selected cells containing cleaved eIF4G. Thus, late vaccinia virus protein synthesis has a low requirement for the intact cap-binding complex eIF4F. This may be attributed to the short unstructured 5'
noncoding regions of the vaccinia virus mRNAs, possibly aided by the
presence of poly(A) at both 5' and 3' termini.
 |
INTRODUCTION |
Vaccinia virus infection of cells
results in the inhibition of host cell protein synthesis and a switch
to the production of virus-encoded polypeptides (reviewed in reference
23). The mechanism underlying this effect is not
established. Vaccinia virus replicates in the cytoplasm of the cell and
encodes its own enzymes for DNA replication and RNA production. The
viral mRNAs are capped (at their 5' terminus) by the virus-encoded
capping enzyme and polyadenylated (at the 3' terminus) and hence have a
structure similar to the host cell cytoplasmic mRNAs. The initiation of
protein synthesis is generally considered to be the key regulatory stage of polypeptide formation (reviewed in reference
22). This step involves the recognition of the
5'-terminal cap structure by the translation initiation complex eIF4F.
This factor is a heterotrimer consisting of eIF4E (which recognizes the
cap structure, m7GpppN...), eIF4A (an RNA helicase), and
eIF4G (believed to act as a scaffold for the other proteins). eIF4F,
probably in association with the 40S ribosomal subunit, is believed to
migrate along the mRNA, unwinding the secondary structure, until an AUG
codon in a suitable context is encountered (18). At this
point the 60S ribosomal subunit joins and polypeptide formation can
commence.
In contrast to cellular mRNAs, the translation of vaccinia virus mRNAs
has been shown to be relatively resistant to inhibition by the cap
analogue m7GTP in vitro, suggesting that the initiation of
protein synthesis on the viral mRNAs is relatively cap independent
(2). An alternative strategy for analyzing the mechanism of
initiation of protein synthesis in vaccinia virus-infected cells has
also been described (11). These authors coexpressed, in a
transient assay, the poliovirus (PV) 2A protease within vaccinia
virus-infected cells and reported a major reduction in the level of
viral protein synthesis. The PV 2A protease induces cleavage of the
eIF4G component of the cap-binding complex eIF4F. This cleavage results
in the inhibition of cap-dependent protein synthesis without affecting
cap-independent translation directed by the picornavirus internal
ribosome entry site (IRES) elements (reviewed in reference
5). These data are also consistent with the
observation that it has been impossible to introduce the PV 2A protease
coding region into the genome of vaccinia virus (16, 33).
Furthermore, a similar incompatibility was observed between vaccinia
virus and the foot-and-mouth disease virus (FMDV) L coding sequence,
which also specifies a protease which cleaves eIF4G (4).
These results appear to suggest that the inhibition of cap-dependent
protein synthesis induced by cleavage of eIF4F is deleterious to
vaccinia virus.
Recently, the isolation of temperature-sensitive (ts)
mutants in the vaccinia virus capping enzyme has been reported
(15). The mutant protein is defective at the nonpermissive
temperature in at least two activities of this enzyme, namely, the
guanyltransferase and methyltransferase activities. The mutant virus is
also markedly ts, as production of virus was reduced several
hundredfold at the nonpermissive temperature. However, it was observed
that little difference in the production of viral proteins could be
detected between the permissive and nonpermissive temperatures. Thus,
it appeared that the viral protein synthesis was relatively independent of the capping of the viral transcripts.
Although there have been a number of studies in which the vaccinia
virus-T7 RNA polymerase transient-expression system has been used to
express, from plasmids, the PV 2A protease or the FMDV Lb protease,
these studies (e.g., references 3, 21, and
25) have not attempted to analyze the effect of
these proteases on the vaccinia virus itself. The studies do show,
however, that these proteases very efficiently inhibit cap-dependent
translation of mRNA transcripts generated from cotransfected plasmids
within vaccinia virus-infected cells. The study of the effects of these proteases on the vaccinia virus mRNA translation itself is complicated by the fact that while all the cells can be readily infected with vaccinia virus, only a proportion of the cells are transfected by
plasmids. Hence, the analysis is hampered by the background of cells
that are not expressing the picornavirus proteases. This background may
mask other effects that these proteases may be causing.
In order to assess specifically the influence of PV 2A and FMDV Lb on
vaccinia virus protein synthesis compared to the cap-dependent translation of a reporter gene construct, we have utilized a recently developed system which selects only those cells which have been transfected. In these selected vaccinia virus-infected cells we have
analyzed, in parallel, the effects of these proteases on reporter gene
expression and also on the vaccinia virus protein synthesis.
 |
MATERIALS AND METHODS |
Plasmids.
The plasmids in this study were constructed by
standard methods as described previously (28) and by the
manufacturers. Plasmid DNA was amplified in Escherichia coli
DH5
and purified by using a Bio 101 Maxi Prep kit (Anachem). pHOOK-1
was obtained from Invitrogen. The construction of the dicistronic
vector pGUS/RXB/HOOK (Fig. 1) will be
described elsewhere (26). Derivatives of this construct that
contain picornavirus IRES elements from FMDV, encephalomyocarditis virus (EMCV), coxsackie B4 virus (CB4) were produced and are also illustrated in Fig. 1. An inactive mutant form of the EMCV IRES (termed
GCGC [see reference 24]) containing a single A-C
change at nucleotide 550 within a conserved GNRA motif was also used. The EMCV plasmids contain EcoRI-BamHI fragments
of EMCV cDNA derived from pSKEMCRB and its mutant derivative
(24) between the unique EcoRI and
BamHI sites of pGUS/RXB/HOOK. The FMDV IRES cDNA (as an
EcoRI-ClaI fragment from pKSRCla
[9]) and the CB4 IRES cDNA (as a
HindIII-SstI fragment from pSKCB4
[31]) were blunt ended and inserted upstream of the
HOOK sequence into the blunt-ended BamHI site (see Fig. 1).
Plasmids of the correct structure were identified from miniprep DNA and
amplified.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Structure of reporter plasmids used in this study. IRES
elements from FMDV, CB4, and both wild-type and mutant forms of EMCV
were positioned between the two cistrons of the parental GUS/RXB/HOOK.
The T7 promoter (filled circle) and unique restriction sites in the
parental vector for EcoRI (R), XbaI (X), and
BamHI (B) are indicated.
|
|
Transient-expression assay and cell selection.
COS-7 cells
(35-mm dishes) were infected with the recombinant vaccinia virus vTF7-3
(12), which expresses the T7 RNA polymerase. The infected
cells were transfected with the pGUS/IRES/HOOK plasmid DNA (2.5 µg)
alone or also with pA
802 (0.5 µg) (which expresses the PV 2A
protease [17]) or pLb (0.5 µg) (which expresses the FMDV Lb protease [21]), or other plasmids as indicated
in the Figure legends by using Lipofectin (8 µg; Life Technologies)
in Optimem as described previously (see reference
6). After about 20 h, cells were harvested for
analysis of gene expression directly by using buffer C (20 mM Tris-HCl,
pH 8.0; 0.135 M NaCl; Nonidet P-40, 0.5%), or else cells expressing
the sFv encoded by the HOOK coding sequence were selected. The cell
selection method will be described in detail elsewhere (26).
Briefly, the cells were removed from the dish by washing in Ca-Mg-free
phosphate-buffered saline (PBS), with an aliquot retained for analysis
of the total cell extracts, and then incubated with the mouse
monoclonal antibody (MAb) 9E10 (specific for the c-myc tag
[10]) for 1 h on ice. After being washed, the
cells were incubated with sheep anti-mouse immunoglobulin G
(IgG)-coated magnetic beads (Dynabeads M-450; Dynal) for 45 min on a
rotating wheel at 4°C. Beads were captured on a magnetic stand
(Dynal) and washed, and the selected cells were extracted in buffer C.
Cell extracts were analyzed by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) (6 or 10%) (
20) and,
where
appropriate, by immunoblotting with rabbit anti-

-glucuronidase
(GUS)
(5prime-3prime, Inc.), rabbit anti-actin (Sigma), rabbit
anti-eIF4G (a
gift from N. Sonenberg, McGill University, Montreal,
Quebec, Canada),
mouse anti-myc tag (9E10 [
10]), or rat monoclonal
antibody 15B6 anti-VVp37 (
29), followed by peroxidase-linked
anti-rabbit, anti-mouse IgG antibodies (Amersham) or anti-rat
IgG
(Dako), as appropriate, with detection by using chemiluminescent
reagents (Pierce).
Protein synthesis was monitored by metabolic labeling with
[
35S]EXPRESS (NEN) (50 µCi/dish) in methionine- and
cysteine-free
medium for 1 h prior to cell selection.
 |
RESULTS |
A system has been developed which permits the isolation of
transfected cells away from untransfected cells dependent on the expression of a cell surface targeted single-chain antibody (sFv) encoded by the plasmid pHOOK-1 (Invitrogen). In order for this system
to function when cap-dependent protein synthesis is blocked, the coding
sequence for the myc-tagged sFv has been placed downstream of picornavirus IRES elements (Fig. 1). The picornavirus IRES elements
direct cap-independent internal initiation of protein synthesis, which
continues in the presence of cleaved eIF4G. Upstream of the IRES
sequence there is a reporter gene sequence encoding GUS. Thus, plasmids
expressing from the T7 promoter mRNAs of the form GUS/IRES/HOOK have
been constructed. A number of versions have been made (see Fig. 1) with
either no IRES element (GUS/RXB/HOOK), a variety of different
picornavirus IRES elements (from EMCV, FMDV, and CB4), or a severely
defective mutant EMCV IRES called GCGC (see reference
24). Transfection of these plasmids into cells
infected with the recombinant vaccinia virus vTF7-3 (12) results in the transcription of these plasmids. In each case the expression of GUS was readily observed by 20 h after infection by
direct analysis of [35S]methionine- and
[35S]cysteine-labeled total cell extracts (Fig.
2A) and was then confirmed by
immunoblotting with anti-GUS antibodies (data not shown). The
polypeptide synthesis observed in these cell extracts is a combination
of that directed by vaccinia virus plus that produced from the T7
transcripts derived from the plasmids transfected into the cells (host
cell protein synthesis is inhibited by vaccinia virus). Expression of
the sFv was dependent on the IRES element. In the absence of the IRES
or with a mutant form of the EMCV IRES (GCGC), no expression of the sFv
was detectable in these labeled cell extracts (Fig. 2A). However,
strong expression of the sFv from the plasmids expressing dicistronic
mRNAs containing the EMCV or FMDV IRES was observed. With the
plasmid expressing the CB4 IRES element, a much-lower expression of the
sFv was obtained (Fig. 2A; see also Fig. 2C).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 2.
IRES-dependent cell selection. The indicated plasmids
were transfected into vTF7-3-infected COS-7 cells as described in
Materials and Methods. Cells were harvested (after metabolic labeling
with [35S]EXPRESS) in Ca-Mg-free PBS, and an aliquot was
retained and analyzed as the total extract (A). Of the remaining cells
those expressing the sFv were selected with MAb 9E10 and anti-mouse
IgG-coated magnetic beads, and the selected cell extracts (panel B)
were analyzed by SDS-PAGE (10%) and autoradiography. The positions of
the GUS and sFv proteins are indicated. Alternatively, selected cell
extracts were analyzed by immunoblotting (panel C) for the presence of
cellular actin (as a measure of cell recovery) and for myc
tagged sFv expression (as a measure of IRES activity).
|
|
Expression of the sFv permitted efficient selection of the transfected
cells. Intact cells were harvested in the absence of trypsin or
detergent by using Ca-Mg-free PBS and incubated with the MAb 9E10 which
recognizes the myc tag on the sFv displayed on the cell
surface. After being washed, the cells which bound the antibody were
isolated by using magnetic beads coated with anti-mouse IgG (as
described in Materials and Methods), and cell extracts were analyzed by
SDS-PAGE (Fig. 2B). In the absence of a functional IRES (GUS/RXB/HOOK
and GUS/GCGC/HOOK) within the construct or when untransfected cells
were used, only a low level of cellular protein was isolated on the
magnetic beads (actin was monitored by Western blot analysis [Fig.
2C]; the actin represents stable accumulated cellular protein, since
all cellular protein synthesis is inhibited by the vaccinia virus
infection). However, all three constructs encoding a functional IRES
element expressed the sFv, and efficient selection of cells was
observed (Fig. 2B and C). Thus, the lower level of sFv achieved by the
CB4 IRES was still sufficient to achieve efficient selection. Within
the selected cell extracts (Fig. 2B), the expression of the upstream cistron, GUS, was even more evident than in the total cell extracts, while the relatively low level expression of the sFv directed by the
CB4 IRES was demonstrated by Western blot analysis, using the
anti-myc-tag MAb 9E10 (Fig. 2C). Thus, in these assays, the vaccinia virus-directed protein synthesis, as well as the cap-dependent and the IRES-directed (cap-independent) translation of the dicistronic mRNA expressed from the plasmids, could each be separately assayed.
To assess the effect of the PV 2A protein or the FMDV Lb protein on the
expression of the reporter gene products and the vaccinia virus
proteins, the GUS/HOOK plasmids were cotransfected with plasmid
pA
802 (17), which expresses PV 2A, or with pLb
(21), which expresses FMDV Lb. Cell extracts were analyzed
either as total cell extracts or after cell selection with MAb 9E10 and the anti-mouse IgG-coated magnetic beads as described above. In the
total cell extracts, the expression of the GUS open reading frame was
readily detected in all of the cells transfected with the GUS/HOOK
constructs alone (Fig. 3A). However, when
cotransfected with plasmids expressing PV 2A (from pA
802) or FMDV Lb
(from pLb), the expression of GUS was greatly inhibited. As expected, no significant change in the IRES-directed expression of the sFv was
observed (Fig. 3A), since the IRES-directed translation occurs when
eIF4G is cleaved. Furthermore, no difference in the pattern of vaccinia
polypeptide synthesis was seen between cell extracts from dishes
transfected with the reporter constructs alone or in combination with
the viral proteases. In these total cell extracts this may be
attributed to the fact that many of the cells will not express the
plasmid-encoded proteases since they have not taken up the DNA. To
overcome this background effect, the infected and transfected cells
were selected and cell extracts were analyzed (Fig. 3B). The
IRES-dependent isolation of transfected cells was still achieved in the
presence of either PV 2A or FMDV Lb as anticipated. In the selected
cell extracts, obtained from cells expressing the GUS/FMD/HOOK,
GUS/EMC/HOOK, and GUS/CB4/HOOK plasmids, the inhibition of GUS
expression in the presence of PV 2A or FMDV Lb was readily apparent
(Fig. 3B). This effect on GUS expression was confirmed by
immunoblotting analysis (Fig. 4A),
although no change in the level of actin isolated was apparent
(reflecting the efficiency of selection and not the pattern of actin
synthesis, which is inhibited in each case by the vaccinia virus
infection). It was also clear that, in contrast to the dramatic drop in
GUS expression, little effect on the pattern of expression of the sFv
or of the vaccinia virus proteins occurred in these extracts (Fig. 3B).
To demonstrate that no change in the accumulation of a vaccinia virus
protein (p37) occurred in the presence of PV 2A or FMDV Lb,
immunoblotting analysis was performed with an anti-VVp37 MAb (MAb 15B6
[29]), revealing very similar levels of this protein in cell extracts obtained from cells with or without the viral proteases (Fig. 4B). Thus, in these selected cell extracts the vast
majority of the cells must have contained the GUS/IRES/HOOK transcript
(or else they would not be selected) and, where appropriate, the PV 2A
or FMDV Lb (to cause the inhibition of GUS expression). Analysis of the
eIF4G within these extracts demonstrated that, in the presence of the
PV 2A or the FMDV Lb proteases, the eIF4G was present predominantly as
the cleaved form (Fig. 4C). The low level of intact eIF4G may be
derived from a small number of untransfected cells which may be
aggregated with the selected cells. Clearly, there is little background
of cells selected in the absence of the selection plasmid (Fig. 4C).

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 3.
Differential regulation of cap-dependent,
IRES-dependent, and vaccinia virus protein synthesis. COS-7 cells were
infected with vTF7-3 and transfected with the indicated GUS/HOOK
plasmids alone or with pA 802 (encodes PV 2A) or pLb (encodes FMDV
Lb). After metabolic labeling with [35S]EXPRESS, cells
were harvested and both total cell extracts (A) and selected cell
extracts (B) were analyzed by SDS-PAGE (10%) and autoradiography as
described in Fig. 2. The positions of the GUS and sFv proteins are
indicated.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 4.
Vaccinia virus protein synthesis is maintained following
cleavage of eIF4G. COS-7 cells were infected with vTF7-3 and
transfected with the indicated GUS/HOOK plasmids alone or with pA 802
(encodes PV 2A) or pLb (encodes FMDV Lb). Selected cell extracts were
prepared and analyzed by immunoblotting for GUS and actin (A), VVp37
(B), and eIF4G (C). The cleavage products (CP) of eIF4G are
indicated.
|
|
Our conclusion from these data is that, in general, the translation of
the vaccinia virus mRNAs is rather insensitive to the loss of intact
eIF4G and hence has only a limited requirement for the cap-binding
complex eIF4F. Since this conclusion is at variance with the results
obtained by Feduchi et al. (11), we sought to investigate
the basis for this disparity. A significant difference between their
studies and those reported here is in the plasmids used to induce eIF4G
cleavage. Feduchi et al. (11) used a derivative of pTM1
which includes an IRES element from EMCV to express the PV 2A, and this
may be expected to yield large amounts of the PV 2A protein. In
contrast, we have used plasmids that lack an IRES element to express PV
2A and FMDV Lb and, furthermore, in the case of the PV 2A plasmid the
initiation codon is the second AUG codon (see reference
17); hence, the expression level obtained is likely
to be much lower than that achieved by Feduchi et al. (11).
The yield of PV 2A and FMDV Lb in our studies is clearly sufficient to
block GUS expression (and to cleave eIF4G), but it may be insufficient
to cause other undefined effects that high-level expression of these
proteases may be able to achieve within cells.
By cotransfecting the GUS/FMD/HOOK selection vector with plasmids
expressing the FMDV L protease with or without an IRES element, we have
sought to test whether this hypothesis may be correct. In Fig.
5, it is shown that significantly fewer
cells (as monitored by the level of virus protein synthesis (Fig. 5A)
and the yield of cellular actin (Fig. 5B) are recovered when the
selection vector is cotransfected with a plasmid expressing FMDV L
(from pSKRHMR1 [3]) protease under the control of an
IRES. In contrast, no significant effect on cell selection or GUS
expression (Fig. 5C) was observed in the presence of a very similar
plasmid (pSKRHCA103 [3]) which has the L gene
specifically inactivated. As seen previously (Fig. 4B), the
coexpression of pLb (which lacks an IRES) had no inhibitory effect on
the cell selection, but it did inhibit GUS expression. Similar results
were also obtained in a parallel experiment with the pGUS/EMC/HOOK
vector (data not shown). These results are consistent with the view
that high-level expression of the viral proteases has a detrimental
effect on protein expression within the vaccinia virus-infected cells
that is unrelated to the cleavage of eIF4G.

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 5.
IRES-directed expression of FMDV L inhibits protein
expression in vaccinia virus-infected cells. COS-7 cells were infected
with vTF7-3 alone (no DNA) or also transfected with pGUS/FMD/HOOK alone
or with one of the following plasmids as indicated: pLb (FMDV Lb),
pSKRHMR1 (FMDV IRES-L-P1-2A+3C) (3), or pSKRHCA103 (FMDV
IRES- L-P1-2A+3C) (3). Cells were labeled with
[35S]EXPRESS and selected as described in Materials and
Methods. Samples of the total cell extracts and extracts of the
selected cells were analyzed by SDS-PAGE and autoradiography (A). The
selected cell extracts were also analyzed by immunoblotting with
antibodies specific for actin (B) or GUS (C) and detected by
chemiluminescence.
|
|
 |
DISCUSSION |
In these studies we have assayed at a gross level the effect of PV
2A and FMDV Lb, which induce cleavage of the eIF4G component of the
cap-binding complex eIF4F, on the translation of reporter gene mRNAs
and vaccinia virus mRNAs in vaccinia virus-infected cells. It is clear
that the cap-dependent expression of GUS from the plasmid construct was
greatly inhibited by the coexpression of the viral proteases, whereas
IRES-directed translation of the sFv and the vaccinia virus mRNA
translation continued efficiently. We have not examined all of the
individual mRNAs produced by vaccinia virus, and it is certainly
possible that particular mRNAs may be more sensitive to the loss of
eIF4G than was indicated by this general analysis. However, since the
pattern of viral protein synthesis observed was identical in each case,
it would appear that the picornavirus proteases had no adverse effect
on any essential early virus function. Our results are consistent with
the relative insensitivity of vaccinia virus mRNA translation in the
rabbit reticulocyte lysate to inhibition by cap analogue
(2). Furthermore, a recent report (15) showed
that a ts lesion in the vaccinia capping enzyme had no
significant effect on the translation of vaccinia virus mRNAs within
infected cells, even at the nonpermissive temperature. These results
suggest that translation of vaccinia virus mRNAs has a low requirement
for the cap-binding complex. These findings are analogous to
observations on the translation of late adenovirus mRNAs containing the
tripartite leader, which also have a low requirement for eIF4F (8,
30). The adenovirus late mRNAs are relatively unstructured in the
5'-proximal portion of their 5'-untranslated region (UTR), and this may
facilitate ribosome attachment in the absence of efficient recognition
of the mRNA by eIF4F. Vaccinia virus mRNAs also have relatively short and unstructured 5' UTRs; indeed, late mRNAs have a capped 5' terminus
followed by a heterogeneous length of poly(A) generated by the viral
RNA polymerase upstream of the initiation codon (23). This
contrasts with the extensive secondary structure and large size (ca.
450 bases) of the picornavirus IRES elements, which also function
without the requirement for intact eIF4F (5). Thus, two
distinct mechanisms of translation initiation with little or no
dependence on the intact eIF4F complex are operating in these assays.
The function of the cap structure on vaccinia virus mRNAs may be to
help stabilize the mRNAs, as decapping of mRNAs leads to rapid
degradation (7).
Our results and conclusions differ from those reported previously
(11), where it was shown that expression of the PV 2A protein in vaccinia virus-infected cells produced a major inhibition of
vaccinia virus protein synthesis. We have demonstrated that the
high-level expression of FMDV L, achieved by the use of an IRES-containing vector to express this protease, is capable of achieving effects on the vaccinia virus that exceed those resulting from the loss of eIF4G and cap-dependent protein synthesis (see Fig.
5). Thus, we believe that the loss of vaccinia virus translation observed earlier (11) was an artifact of that experimental
system.
Very recently, a functional homologue of eIF4G, termed eIF4GII, has
been reported (14). Since the cap-dependent expression of
GUS is clearly inhibited when either FMDV L or PV 2A proteases are
expressed, it is apparent that no functional homologue of eIF4G can
persist under these conditions. Furthermore, we have now demonstrated
that eIF4GII is also cleaved in the vaccinia-T7 RNA polymerase
transient-expression system by using the plasmids that express FMDV Lb
and PV 2A (6a). Thus, the vaccinia virus mRNAs are
translated when both forms of eIF4G are cleaved.
Earlier reports had indicated that constitutive expression of PV 2A or
FMDV Lb within recombinant vaccinia virus was not tolerated (4,
16, 33), since such recombinant viruses could not be isolated.
Interruption or elimination of the FMDV L coding sequence within FMDV
cassettes greatly facilitated the production of recombinant FMDV-vaccinia viruses (1, 4). It should be noted, however, that even when only low-level expression of the PV 2A or FMDV L
proteases could be expected (i.e., when the coding sequence was not
specifically positioned under the control of a vaccinia virus promoter
[4, 33]), it was still not possible to isolate recombinant vaccinia viruses, suggesting that the toxic effects of
these proteases is apparent even at low levels. The incompatibility of
vaccinia virus with PV 2A or FMDV Lb may represent effects on a minor
population of mRNAs or, alternatively, may reflect only a small
diminution in replication efficiency that is amplified by the
multiple cycles of virus growth required to generate plaques.
In conclusion, the results presented here clearly demonstrate that
vaccinia virus protein synthesis proceeds efficiently when the
cap-binding complex (eIF4F) is inactivated through the cleavage of the
eIF4G component. Thus, initiation of protein synthesis on these viral
mRNAs appears to be accomplished with a low requirement for this
translation initiation complex; this is probably as a result of the
short, unstructured nature of the 5' UTRs of the vaccinia virus mRNAs.
It is interesting to note that, since late vaccinia virus mRNAs have a
stretch of poly(A) at both their 5' and 3' termini, interaction with a
protein which recognizes poly(A) could bring the two termini into close
proximity. This may facilitate the recycling of ribosomes from the 3'
terminus to the 5' end with little requirement for eIF4F. This is
similar to the model for poly(A)-stimulated translation initiation
within yeast cells, as described previously (27), suggesting
circularization of mRNA resulting from the interaction between the
poly(A) binding protein (PABP) and eIF4G (32). Within
mammalian cells no evidence for a direct interaction between these two
proteins has been presented. However, a PABP-interacting protein
that interacts with both PABP and eIF4A has very recently been
characterized (6b) that can also bridge the two mRNA
termini. In vaccinia virus-infected cells, circularization could also
be achieved by the vaccinia virus poly(A) polymerase, a dimer of VP55
and VP39 (23) that has affinity for both poly(A) and the 5'
cap structure. Alternatively, perhaps the abundant cellular
PABP could achieve this function alone on vaccinia virus mRNAs,
since it has four RNA recognition motifs and has the ability to
multimerize (13, 19).
 |
ACKNOWLEDGMENTS |
We thank Tom Wileman (Pirbright) for the anti-c-myc
and anti-VVp37 antibodies, Nahum Sonenberg (Montreal) for the
anti-eIF4G antibodies, and Ann Kaminski (Cambridge) for the plasmids
pA
802.
M.E.M.R. was supported by a BBSRC studentship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: BBSRC Institute
for Animal Health, Pirbright Laboratory, Ash Road, Pirbright, Woking, Surrey GU24 ONF, United Kingdom. Phone: 44-1483 232441. Fax: 44-1483 232448. E-mail: graham.belsham{at}bbsrc.ac.uk.
 |
REFERENCES |
| 1.
|
Abrams, C. C.,
A. M. Q. King, and G. J. Belsham.
1995.
Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system.
J. Gen. Virol.
76:3089-3098[Abstract/Free Full Text].
|
| 2.
|
Bablanian, R.,
S. K. Goswami,
M. Esteban,
A. K. Banerjee, and W. C. Merrick.
1991.
Mechanism of selective translation of vaccinia virus mRNAs: differential role of poly(A) and initiation factors in the translation of viral and cellular mRNAs.
J. Virol.
65:4449-4460[Abstract/Free Full Text].
|
| 3.
|
Belsham, G. J., and J. K. Brangwyn.
1990.
A region of the 5' non-coding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells: involvement with the role of L protease in translational control.
J. Virol.
64:5389-5395[Abstract/Free Full Text].
|
| 4.
|
Belsham, G. J.,
J. K. Brangwyn,
M. D. Ryan,
C. C. Abrams, and A. M. Q. King.
1990.
Intracellular expression and processing of foot-and-mouth disease virus capsid precursors using vaccinia virus vectors: influence of the L protease.
Virology
176:524-530[Medline].
|
| 5.
|
Belsham, G. J., and N. Sonenberg.
1996.
RNA protein interactions in regulation of picornavirus RNA translation.
Microbiol. Rev.
60:499-511[Abstract/Free Full Text].
|
| 6.
|
Belsham, G. J.
1997.
Analysis of picornavirus internal ribosome entry site function in vivo, p. 323-340.
In
J. Richter (ed.), mRNA formation and function. Academic Press, Inc., New York, N.Y.
|
| 6a.
| Belsham, G. J., and N. Sonenberg. Unpublished
results.
|
| 6b.
|
Craig, A.,
A. Haghighat,
A. T. K. Yu, and N. Sonenberg.
1998.
Interaction of polyadenylate-binding protein with eIF4G homologue PAIP enhances translation.
Nature
392:520-523[Medline].
|
| 7.
|
Decker, C. J., and R. Parker.
1994.
Mechanism of mRNA degradation in eukaryotes.
Trends Biochem. Sci.
19:336-340[Medline].
|
| 8.
|
Dolph, P. J.,
J. Huang, and R. J. Schneider.
1990.
Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex.
J. Virol.
64:2669-2677[Abstract/Free Full Text].
|
| 9.
|
Drew, J., and G. J. Belsham.
1994.
trans complementation by RNA of defective foot-and-mouth disease virus internal ribosome entry site elements.
J. Virol.
68:697-703[Abstract/Free Full Text].
|
| 10.
|
Evan, G. I.,
G. K. Lewis,
G. Ramsay, and K. M. Bishop.
1985.
Isolation of monoclonal antibodies specific for c-myc proto-oncogene product.
Mol. Cell. Biol.
5:3610-3616[Abstract/Free Full Text].
|
| 11.
|
Feduchi, E.,
R. Aldabe,
I. Novoa, and L. Carrasco.
1995.
Effect of poliovirus 2Apro on vaccinia virus gene expression.
Eur. J. Biochem.
234:849-854[Medline].
|
| 12.
|
Fuerst, T. R.,
E. G. Niles,
F. W. Studier, and B. Moss.
1986.
Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:8122-8126[Abstract/Free Full Text].
|
| 13.
|
Gorlach, M.,
C. G. Burd, and G. Dreyfuss.
1994.
The mRNA poly(A)-binding protein: localization, abundance, and RNA-binding specificity.
Exp. Cell. Res.
211:400-407[Medline].
|
| 14.
|
Gradi, A.,
H. Imataka,
Y. V. Svitkin,
E. Rom,
B. Raught, and N. Sonenberg.
1998.
A novel functional human eukaryotic translation initiation factor 4G.
Mol. Cell. Biol.
18:334-342[Abstract/Free Full Text].
|
| 15.
|
Hassett, D. E.,
J. I. Lewis,
X. Xing,
L. DeLange, and R. C. Condit.
1997.
Analysis of a temperature-sensitive vaccinia virus mutant in the viral capping enzyme isolated by clustered charge-to-alanine mutagenesis and transient dominant selection.
Virology
238:391-409[Medline].
|
| 16.
|
Jewell, J. E.,
L. A. Ball, and R. R. Rueckert.
1990.
Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.
J. Virol.
64:1388-1393[Abstract/Free Full Text].
|
| 17.
|
Kaminski, A.,
M. T. Howell, and R. J. Jackson.
1990.
Initiation of encephalomyocarditis virus RNA translation: the authentic initiation site is not selected by a scanning mechanism.
EMBO J.
9:3753-3759[Medline].
|
| 18.
|
Kozak, M.
1989.
The scanning model for translation: an update.
J. Cell Biol.
108:229-241[Abstract/Free Full Text].
|
| 19.
|
Kuhn, U., and T. Pieler.
1996.
Xenopus poly(A) binding protein: functional domains in RNA binding and protein-protein interaction.
J. Mol. Biol.
256:20-30[Medline].
|
| 20.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 21.
|
Medina, M.,
E. Domingo,
J. K. Brangwyn, and G. J. Belsham.
1993.
The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities.
Virology
194:355-359[Medline].
|
| 22.
|
Merrick, W. C., and J. W. B. Hershey.
1996.
The pathway and mechanism of eukaryotic protein synthesis, p. 31-69.
In
J. W. B. Hershey, M. B. Mathews, and N. Sonenberg (ed.), Translational control. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 23.
|
Moss, B.
1996.
Poxviridae: the viruses and their replication, p. 2637-2671.
In
B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 24.
|
Roberts, L. O., and G. J. Belsham.
1997.
Complementation of defective picornavirus internal ribosome entry site (IRES) elements by the coexpression of fragments of the IRES.
Virology
227:53-62[Medline].
|
| 25.
|
Roberts, L. O.,
R. A. Seamons, and G. J. Belsham.
1998.
Recognition of picornavirus internal ribosome entry sites within cells: influence of cellular and viral proteins.
RNA
4:520-529[Abstract].
|
| 26.
| Robertson, M. E. M., R. A. Seamons, and
G. J. Belsham. Submitted for publication.
|
| 27.
|
Sachs, A. B.,
P. Sarnow, and M. W. Hentze.
1997.
Starting at the beginning, middle, and end: translation initiation in eukaryotes.
Cell
89:831-838[Medline].
|
| 28.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 29.
|
Schmelz, M.,
B. Sodeik,
M. Ericsson,
E. J. Wolffe,
H. Shida,
G. Hiller, and G. Griffiths.
1994.
Assembly of vaccinia virus the second wrapping cisterna is derived from the trans-golgi network.
J. Virol.
68:130-147[Abstract/Free Full Text].
|
| 30.
|
Schneider, R. J.
1995.
Cap-independent translation in adenovirus-infected cells.
Curr. Top. Microbiol. Immunol.
203:117-129[Medline].
|
| 31.
|
Stone, D. M.,
J. W. Almond,
J. K. Brangwyn, and G. J. Belsham.
1993.
trans complementation of cap-independent translation directed by poliovirus 5' noncoding region deletion mutants: evidence for RNA-RNA interactions.
J. Virol.
67:6215-6223[Abstract/Free Full Text].
|
| 32.
|
Tarun, S. Z., and A. B. Sachs.
1996.
Association of the yeast poly(A) tail binding protein with translation initiation factor eIF4G.
EMBO J.
15:7168-7177[Medline].
|
| 33.
|
Turner, P. C.,
D. C. Young,
J. B. Flanegan, and R. W. Moyer.
1989.
Interference with vaccinia virus growth caused by insertion of the coding sequence for poliovirus protease 2A.
Virology
173:509-521[Medline].
|
Journal of Virology, November 1998, p. 8813-8819, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zaborowska, I., Walsh, D.
(2009). PI3K Signaling Regulates Rapamycin-Insensitive Translation Initiation Complex Formation in Vaccinia Virus-Infected Cells. J. Virol.
83: 3988-3992
[Abstract]
[Full Text]
-
Shirokikh, N. E., Spirin, A. S.
(2008). Poly(A) leader of eukaryotic mRNA bypasses the dependence of translation on initiation factors. Proc. Natl. Acad. Sci. USA
105: 10738-10743
[Abstract]
[Full Text]
-
Walsh, D., Arias, C., Perez, C., Halladin, D., Escandon, M., Ueda, T., Watanabe-Fukunaga, R., Fukunaga, R., Mohr, I.
(2008). Eukaryotic Translation Initiation Factor 4F Architectural Alterations Accompany Translation Initiation Factor Redistribution in Poxvirus-Infected Cells. Mol. Cell. Biol.
28: 2648-2658
[Abstract]
[Full Text]
-
Gilbert, W. V., Zhou, K., Butler, T. K., Doudna, J. A.
(2007). Cap-Independent Translation Is Required for Starvation-Induced Differentiation in Yeast. Science
317: 1224-1227
[Abstract]
[Full Text]
-
Clark, A. T., Robertson, M. E. M., Conn, G. L., Belsham, G. J.
(2003). Conserved Nucleotides within the J Domain of the Encephalomyocarditis Virus Internal Ribosome Entry Site Are Required for Activity and for Interaction with eIF4G. J. Virol.
77: 12441-12449
[Abstract]
[Full Text]